Division of Social Studies, Department of Health, Universidad Iberoamericana, Prolongación Paseo de la Reforma 880, Col. Lomas de Santa Fe, C.P. 01219, Álvaro Obregón, Mexico City, Mexico.
Medical Division, Department of Gynecology, Instituto Nacional de Perinatología "Isidro Espinosa de los Reyes", C.P. 11000, Miguel Hidalgo, Mexico City, Mexico.
BMC Womens Health. 2022 Aug 26;22(1):356. doi: 10.1186/s12905-022-01941-5.
Endometriosis is an estrogen-dependent and chronic inflammatory disease affecting up to 10% of women. It is the result of a combined interaction of genetic, epigenetic, environmental, lifestyle, reproductive and local inflammatory factors. In this study, we investigated whether single nucleotide polymorphisms (SNPs) mapping to TNF-alpha (TNF, rs1800629) and IL-1beta (IL1B, rs1143634) and variable number tandem repeat polymorphism mapping to IL1-Ra (IL1RN intron 2, rs2234663) genetic loci are associated with risk for endometriosis in a Mexican mestizo population.
This study included 183 women with confirmed endometriosis (ENDO) diagnosed after surgical laparoscopy and 186 women with satisfied parity and without endometriosis as controls (CTR). PCR/RFLP technique was used for genotyping SNPs (rs1800629 and rs1143634); PCR for genotyping rs2234663.
We found no statistical differences in age between groups nor among stages of endometriosis and the CTR group. We observed no difference in genotype and allele frequencies, nor carriage rate between groups in none of the three studied polymorphisms. The prevalence of TNF2-allele heterozygotes (p = 0.025; OR 3.8), TNF2-allele (p = 0.029; OR 3.4), IL1B2-allele heterozygotes (p = 0.044; OR 2.69) and its carriage rate (p = 0.041; OR 2.64) in endometriosis stage IV was higher than the CTR group. Surprisingly, the carriage rate of IL1RN2-allele (ENDO: p = 0.0004; OR 0.4; stage I: p = 0.002, OR 0.38; stage II: p = 0.002, OR 0.35; stage III: p = 0.003, OR 0.33), as well as the IL1RN2-allele frequencies (ENDO: p = 0.0008, OR 0.55; I: p = 0.037, OR 0.60; II: p = 0.002, OR 0.41; III: p = 0.003, OR 0.38) were lower than the CTR group. Women with endometriosis stage IV (severe) had frequencies more alike to the CTR group in the IL1RN2 allele frequency (31.2% vs. 27.2%) and carriage rate (37.5% vs. 41.9%).
Although these polymorphisms are not associated with the risk of endometriosis, Mexican mestizo women with severe stage of endometriosis have higher frequencies of TNF2-, IL1B2- and IL1RN*2-alleles, which may explain a possible correlation with disease severity rather than predisposition or risk.
子宫内膜异位症是一种雌激素依赖性的慢性炎症性疾病,影响多达 10%的女性。它是遗传、表观遗传、环境、生活方式、生殖和局部炎症因素综合作用的结果。在这项研究中,我们研究了单核苷酸多态性(SNP)是否与肿瘤坏死因子-α(TNF,rs1800629)和白细胞介素-1β(IL1B,rs1143634)和白细胞介素 1 受体拮抗剂(IL1RN 内含子 2,rs2234663)的遗传位点与墨西哥梅斯蒂索人群中子宫内膜异位症的风险相关。
本研究包括 183 名经手术腹腔镜确诊为子宫内膜异位症(ENDO)的女性和 186 名满足生育要求且无子宫内膜异位症的对照(CTR)女性。PCR/RFLP 技术用于 SNP(rs1800629 和 rs1143634)的基因分型;PCR 用于 rs2234663 的基因分型。
我们发现组间和子宫内膜异位症各期与 CTR 组之间在年龄上无统计学差异。在三组研究的多态性中,我们没有观察到基因型和等位基因频率或携带率的差异。TNF2-等位基因杂合子(p=0.025;OR 3.8)、TNF2-等位基因(p=0.029;OR 3.4)、IL1B2-等位基因杂合子(p=0.044;OR 2.69)和其携带率(p=0.041;OR 2.64)在子宫内膜异位症 IV 期的发生率高于 CTR 组。令人惊讶的是,IL1RN2-等位基因(ENDO:p=0.0004;OR 0.4;I 期:p=0.002,OR 0.38;II 期:p=0.002,OR 0.35;III 期:p=0.003,OR 0.33)的携带率以及 IL1RN2-等位基因频率(ENDO:p=0.0008,OR 0.55;I:p=0.037,OR 0.60;II:p=0.002,OR 0.41;III:p=0.003,OR 0.38)均低于 CTR 组。患有子宫内膜异位症 IV 期(严重)的女性在 IL1RN2 等位基因频率(31.2%比 27.2%)和携带率(37.5%比 41.9%)方面与 CTR 组更相似。
尽管这些多态性与子宫内膜异位症的风险无关,但患有严重子宫内膜异位症的墨西哥梅斯蒂索女性具有更高频率的 TNF2-、IL1B2-和 IL1RN*2-等位基因,这可能解释了它们与疾病严重程度而不是易感性或风险的可能相关性。